Macrogenics (MGNX) Interest Expenses (2012 - 2026)

Macrogenics' (MGNX) quarterly Interest Expenses came in at $5.5 million in Q1 2026, up 5909.89% year-on-year from $91000.0 in Q1 2025, and up 28.02% on a QoQ basis from $4.3 million in Q4 2025.

Macrogenics (MGNX) Interest Expenses (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has 15 years of Interest Expenses data on file, last reported at $5.5 million in Q1 2026.

  • On a quarterly basis, Interest Expenses rose 5909.89% year-over-year to $5.5 million in Q1 2026; TTM through Mar 2026 was $5.5 million, a 7391.78% increase from a year earlier, with the FY2025 full-year figure at $8.5 million, down 97.88% from the prior year.
  • Interest Expenses for Q1 2026 stood at $5.5 million, up from $4.3 million in the prior quarter.
  • Over the last five years, Interest Expenses for MGNX reached as high as $46.4 million in Q1 2024 and fell as low as -$24000.0 in Q4 2024.
  • Historically, Interest Expenses has averaged $6.5 million across 5 years, with a median of $2.1 million in 2023.
  • On a YoY basis, Interest Expenses climbed as much as 17900.0% in 2025 and fell as far as 99.8% in 2025.
  • Year by year, Interest Expenses stood at $904000.0 in 2022, then soared by 131.53% to $2.1 million in 2023, then sank by 101.15% to -$24000.0 in 2024, then jumped by 17900.0% to $4.3 million in 2025, then gained by 28.02% to $5.5 million in 2026.
  • Per Business Quant data, the three most recent Interest Expenses figures were $5.5 million in Q1 2026, $4.3 million in Q4 2025, and $3.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -42,141.15
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 100,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 32.89 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.17 Bn
10 Macrogenics 230.64 Mn 164.12 Mn - 5.47 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.47 Mn
Mar 31, 2026 5.47 Mn
Dec 31, 2025 4.27 Mn
Dec 31, 2025 4.27 Mn
Sep 30, 2025 3.34 Mn
Sep 30, 2025 3.34 Mn
Jun 30, 2025 802,000.00
Jun 30, 2025 802,000.00
Mar 31, 2025 91,000.00
Mar 31, 2025 91,000.00
Dec 31, 2024 -24,000.00
Dec 31, 2024 -24,000.00
Jun 30, 2024 6,000.00
Jun 30, 2024 6,000.00
Mar 31, 2024 46.45 Mn
Mar 31, 2024 46.45 Mn
Jun 30, 2023 2.09 Mn
Jun 30, 2023 2.09 Mn
Mar 31, 2023 7.83 Mn
Mar 31, 2023 7.83 Mn